Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes

Abstract The effectiveness of intravenous immunoglobulin (IVIg) for patients with unexplained recurrent implantation failure (uRIF) remains debated. We retrospectively analysed outcomes of uRIF patients treated with IVIg compared to a separate control uRIF cohort within our center (01/2014–12/2021)....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Einav Kadour Peero, Shorooq Banjar, Rabea Khoudja, Shaonie Ton-leclerc, Coralie Beauchamp, Joanne Benoit, Marc Beltempo, Michael H. Dahan, Phil Gold, Isaac Jacques Kadoch, Wael Jamal, Carl Laskin, Neal Mahutte, Simon Phillips, Camille Sylvestre, Shauna Reinblatt, Bruce D. Mazer, William Buckett, Genevieve Genest
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2024-02-01
coleção:	Scientific Reports
Assuntos:	Unexplained recurrent implantation failure Intravenous immunoglobulin Reproductive immunology Immune-mediated recurrent implantation failure
Acesso em linha:	https://doi.org/10.1038/s41598-024-54423-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!